[go: up one dir, main page]

Hofmann et al., 1983 - Google Patents

Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery: Oxalogenic substances in diet contribute to urinary oxalate

Hofmann et al., 1983

Document ID
14990396204882036116
Author
Hofmann A
Laker M
Dharmsathaphorn K
Sherr H
Lorenzo D
Publication year
Publication venue
Gastroenterology

External Links

Snippet

Balance studies and oxalate loading tests were carried out in order to define the pathogenesis of hyperoxa1uria in 8 patients with jejunoi1ea1 bypass surgery for severe obesity; two healthy volunteers were also studied. In the bypass patients, urinary oxalate …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Hofmann et al. Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery: Oxalogenic substances in diet contribute to urinary oxalate
Seguy et al. Low-dose growth hormone in adult home parenteral nutrition–dependent short bowel syndrome patients: A positive study
Gruy-Kapral et al. Conjugated bile acid replacement therapy for short-bowel syndrome
Nightingale Management of patients with a short bowel
Earnest et al. Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption
Garbutt et al. Effect of cholestyramine on bile acid metabolism in normal man
Thomson et al. Liver damage and impaired glucose tolerance after paracetamol overdosage
Lennard‐Jones Practical management of the short bowel
STAUFFER et al. Acquired hyperoxaluria with regional enteritis after ileal resection: role of dietary oxalate
Jeppesen et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon
Hardison Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine
Becker et al. Postgastrectomy and postvagotomy syndromes
Milner et al. Intestinal malabsorption in Strongyloides stercoralis infestation
Jeppesen et al. Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients. A randomized, double-blind, crossover, placebo-controlled study
Emmett et al. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome
WO1998015196A1 (en) Compositions for postgastrectomic mineral supply
Owen et al. Renal tubular disease with muscle paralysis and hypokalemia
Twersky et al. Nutritional deficiencies in chronic pancreatitis
WO1980001415A1 (en) Test for pancreatic exocrine function
Andersson et al. Hyperoxaluria in malabsorptive states
Kelly et al. Effect of meal composition on calcium absorption: enhancing effect of carbohydrate polymers
Colcher et al. Management of intractable sprue with cortisone and adrenocorticotropin (ACTH)
Kapral et al. Conjugated bile acid replacement therapy in short bowel syndrome patients with a residual colon
Fausa et al. Intractable watery diarrhoea, hypokalaemia, and achlorhydria associated with non-pancreatic retroperitoneal neurogenous tumour containing vasoactive intestinal peptide (VIP)
Gonella et al. Factors affecting the metabolic production of methylguanidine